NCT01975272

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

The Value of Iron Treatment for Postoperative Obstetric Patients With Anemia: a Randomized Double Blind Controlled Trial

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 27 (actual)
• Sponsor: Maastricht University Medical Center · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether oral or intravenous iron is effective in the treatment of anaemia (iron-poor blood) after caesarean section.

Detailed description

Anemia after caesarean section is often treated with iron therapy to ensure that the hemoglobin will return to normal more rapidly. Scientific evidence for this action is limited. Several studies, in which iron therapy was given after orthopaedic or cardiac surgery, show that after 6 to 10 weeks the hemoglobin was not significantly different between patients treated with oral preparations and patients treated with a placebo. These studies have not examined the hemoglobin level during the first few weeks after surgery including the quality of life analysis. The purpose of this double blind randomized controlled trial therefore is to examine the effect of both oral iron therapy and intravenous iron therapy on hemoglobin level and on the quality of life during the first few weeks postcaesarean in patients with a moderate anemia.

Conditions

• Postoperative Anaemia

Interventions

Type	Name	Description
DRUG	Ferinject
DRUG	Ferrous fumarate
DRUG	Placebo for ferrous fumarate
DRUG	Placebo for ferinject

Timeline

• Start date: 2015-03-02
• Primary completion: 2018-05-17
• Completion: 2018-06-21
• First posted: 2013-11-04
• Last updated: 2022-08-22
• Results posted: 2022-08-22

Locations

2 sites across 1 country: Netherlands